Literature DB >> 15650356

Cytoplasmic localization of the paired box gene, Pax-8, is found in pediatric thyroid cancer and may be associated with a greater risk of recurrence.

William T Scouten1, Aneeta Patel, Richard Terrell, Henry B Burch, Victor J Bernet, R Michael Tuttle, Gary L Francis.   

Abstract

The paired box-8 protein (Pax-8) has been observed in the nucleus of normal adult thyroids, follicular adenomas, follicular thyroid cancers, and papillary thyroid cancers (PTC) but not undifferentiated thyroid cancers. To our knowledge, Pax-8 has not been studied in pediatric thyroid cancer. Because of the more favorable prognosis for PTC in children compared to young patients, we hypothesized that Pax-8 expression might be different in pediatric thyroid cancers. To test this, we stained 47 thyroid lesions from children and young patients for Pax-8. Pax-8 was located in the cytoplasm (cPAX) or nucleus (nPAX) in the majority of samples. There was no significant difference in nPAX between benign and malignant lesions. However, cPAX was more commonly seen in PTC than autoimmune diseases (p = 0.01) and the intensity of cPAX staining correlated with tumor size (p = 0.041), metastasis, age, completeness of resection, local invasion, and tumor size (MACIS) scores (p = 0.045), and the presence of invasion, metastasis, recurrence, or persistence (p = 0.012). Disease-free survival was significantly reduced for cancers with intense cPAX staining (p = 0.0003). These data show that cPAX is common in PTC, and although limited by small sample size, suggest an association with higher MACIS scores, an aggressive clinical course, and an increased risk of clinically evident recurrence for children and young patients.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15650356     DOI: 10.1089/thy.2004.14.1037

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  6 in total

1.  PAX-8 expression in renal tumours and distant sites: a useful marker of primary and metastatic renal cell carcinoma?

Authors:  Meaghan L Barr; Lucia B Jilaveanu; Robert L Camp; Adebowale J Adeniran; Harriet M Kluger; Brian Shuch
Journal:  J Clin Pathol       Date:  2014-10-14       Impact factor: 3.411

2.  PAX5 is expressed in small-cell lung cancer and positively regulates c-Met transcription.

Authors:  Rajani Kanteti; Vidya Nallasura; Sivakumar Loganathan; Maria Tretiakova; Todd Kroll; Soundararajan Krishnaswamy; Leonardo Faoro; Philip Cagle; Aliya N Husain; Everett E Vokes; Deborah Lang; Ravi Salgia
Journal:  Lab Invest       Date:  2009-01-12       Impact factor: 5.662

3.  Genome-wide analysis of Pax8 binding provides new insights into thyroid functions.

Authors:  Sergio Ruiz-Llorente; Enrique Carrillo Santa de Pau; Ana Sastre-Perona; Cristina Montero-Conde; Gonzalo Gómez-López; James A Fagin; Alfonso Valencia; David G Pisano; Pilar Santisteban
Journal:  BMC Genomics       Date:  2012-04-24       Impact factor: 3.969

4.  Small-Intestinal Metastasis from Lung Carcinoma.

Authors:  Naotaka Ogasawara; Satoshi Ono; Tomoya Sugiyama; Kazunori Adachi; Yoshiharu Yamaguchi; Shinya Izawa; Masahide Ebi; Yasushi Funaki; Makoto Sasaki; Kunio Kasugai
Journal:  Case Rep Gastroenterol       Date:  2022-03-31

5.  A multi-gene approach to differentiate papillary thyroid carcinoma from benign lesions: gene selection using support vector machines with bootstrapping.

Authors:  Krzysztof Fujarewicz; Michal Jarzab; Markus Eszlinger; Knut Krohn; Ralf Paschke; Małgorzata Oczko-Wojciechowska; Małgorzata Wiench; Aleksandra Kukulska; Barbara Jarzab; Andrzej Swierniak
Journal:  Endocr Relat Cancer       Date:  2007-09       Impact factor: 5.678

6.  Role of PAX8 in the regulation of MET and RON receptor tyrosine kinases in non-small cell lung cancer.

Authors:  Rajani Kanteti; Essam El-Hashani; Immanuel Dhanasingh; Maria Tretiakova; Aliya N Husain; Sherven Sharma; Jay Sharma; Everett E Vokes; Ravi Salgia
Journal:  BMC Cancer       Date:  2014-03-14       Impact factor: 4.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.